This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Antibodies, Neoplasm
and you are
between 1 and 21
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

patients with progressive/relapsed solid tumors who failed first line therapy , will be treated biweekly with the anti PD1- Nivolumab. at least one month after treatment initiation low dose cyclophosphamide will be started . patients on trial will submit tissue and blood tests for whole exome an immune genomic signature. patients will also undergo repeated immunophenotype as part of follow up.

Provided treatments

  • Drug: Nivolumab,low dose cyclophosphamide

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02901145. The sponsor of the trial is Hadassah Medical Organization and it is looking for 30 volunteers for the current phase.
Official trial title:
A Phase I/II Clinical Trial of Nivolumab in Progressive/Relapsed Pediatric Solid Tumors